Summary

About the company

Die Kernaktivität von AdRegeneer AG ist die Entwicklung von regenerativen Medikamenten für das Nervensystem, insbesondere für die Behandlung von Multipler Sklerose und Rückenmarksverletzungen.

AI-generated

Knowledge

No knowledge articles yet

Once ABBA Therapeutics AG claims this profile, we will publish editorial articles and case studies together here.

Get started

Comparisons

ABBA Therapeutics AG in comparison

Soon

Industry comparisons are coming soon

We are preparing industry comparisons in which ABBA Therapeutics AG will be ranked by reviews, experience and specialisations.